Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Market news: South Korean court issued an arrest warrant to Seoul police chief.Guoyuan Securities: A special dividend plan was drawn up and announced by Guoyuan Securities. On December 13, 2024, the company held the 20th meeting of the 10th Board of Directors and the 11th meeting of the 10th Board of Supervisors, at which the Proposal on Special Dividend Plan was reviewed and approved. As of September 30, 2024, the accumulated undistributed profit of the company was 7.743 billion yuan, and the accumulated distributable profit of the parent company was 5.262 billion yuan. In order to enhance the investor's sense of gain and improve the investor's return level, the company has drawn up a special dividend plan: based on the existing total share capital of 4.364 billion shares, a cash dividend of 0.60 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 262 million yuan will be distributed. No bonus shares will be distributed, and capital will not be increased from the provident fund.
As a result of providing loans with private fund property, Haisi Quanzong's private placement and responsible person were supervised to issue a warning letter. On December 13th, Qingdao Securities Regulatory Bureau issued a notice saying that after investigation, Qingdao Haisi Quanzong Private Fund Management Co., Ltd. (hereinafter referred to as "Haisi Quanzong Private Placement") provided loans with private fund property, which violated the regulations. Song Xiuhong was then the legal representative and chairman of Haisi Quanzong Private Equity, and Liu Jialiang is now the legal representative and chairman of Haisi Quanzong Private Equity. Since the establishment of Haisi Quanzong Private Equity, Wang Zhaohui has been the general manager. During his tenure, he failed to fulfill his duties and strictly abide by laws and regulations, and was responsible for the above acts. Qingdao Securities Regulatory Bureau took administrative supervision measures to issue warning letters to Haisi Quanzong Private Equity, Song Xiuhong, Liu Jialiang and Wang Chaohui.Weilai announced that the number of power exchanges had exceeded 60 million times. Weilai issued a document saying that as of 21:06:08 on December 13th, 2024, Weilai had changed power more than 60 million times! Thank you for your support and trust in Weilai.In November, the real effective interest rate of the Russian ruble decreased by 1.6% from the previous month.
Market News: The United Arab Emirates will restrict oil transportation in the case of OPEC+promoting compliance with quotas.Institution: The sinking trend of the domestic market is remarkable. The Report on Career Development of Domestic Servants released in 58 shows that in 2024, the demand for nursing old nannies will increase by 21% year-on-year, the demand for raising children will increase by 23%, and the demand for high-end domestic services such as elite housekeepers and children's growth companions will increase by 34%. In addition, the sinking trend of domestic training is obvious, and the number of participants in second-tier and below cities has increased by 229% year-on-year.Kangxinuo Bio: Dong Xiaoman was appointed as the new general partner of Shanghai Qianxizhi, and Kangxinuo Bio (06185) issued an announcement. On December 13, 2024, Dr. Zhu informed the board of directors that in view of the need for sufficient time to manage the employee stock ownership platform, all the partners of the employee stock ownership platform unanimously decided to appoint Well Lee as the new general partner of Shanghai Qianxiyi and Shanghai Qianxirui respectively, and Dong Xiaoman as the new general partner of Shanghai Qianxizhi. Therefore, Dr. Zhu is no longer the general partner of the employee stock ownership platform and no longer has the right to exercise the voting rights of the shares held by the employee stock ownership platform.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14